113 related articles for article (PubMed ID: 3143476)
1. Effect of toxins produced by various Clostridium difficile strains on cecum size reduction in gnotobiotic mice.
Mahé S; Corthier G
Can J Microbiol; 1988 Jul; 34(7):916-8. PubMed ID: 3143476
[TBL] [Abstract][Full Text] [Related]
2. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.
Mahe S; Corthier G; Dubos F
Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxin and enterotoxin production by Clostridium difficile.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of appearance of intestinal lesions in mice mono-associated with a lethal or non-lethal strain of Clostridium difficile.
Castex F; Jouvert S; Bastide M; Corthier G
J Med Microbiol; 1994 Feb; 40(2):102-9. PubMed ID: 8107057
[TBL] [Abstract][Full Text] [Related]
5. Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice.
Vernet A; Corthier G; Dubos-Ramaré F; Parodi AL
Infect Immun; 1989 Jul; 57(7):2123-7. PubMed ID: 2499546
[TBL] [Abstract][Full Text] [Related]
6. Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one.
Corthier G; Muller MC
Infect Immun; 1988 Jun; 56(6):1500-4. PubMed ID: 3372017
[TBL] [Abstract][Full Text] [Related]
7. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
8. Pseudomembranous colitis in Clostridium difficile-monoassociated rats.
Czuprynski CJ; Johnson WJ; Balish E; Wilkins T
Infect Immun; 1983 Mar; 39(3):1368-76. PubMed ID: 6840842
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.
Corthier G; Dubos F; Ducluzeau R
Can J Microbiol; 1986 Nov; 32(11):894-6. PubMed ID: 3815159
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria.
Corthier G; Dubos F; Raibaud P
Appl Environ Microbiol; 1985 Jan; 49(1):250-2. PubMed ID: 3977313
[TBL] [Abstract][Full Text] [Related]
11. Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo.
Barc MC; Depitre C; Corthier G; Collignon A; Su WJ; Bourlioux P
Antimicrob Agents Chemother; 1992 Jun; 36(6):1332-5. PubMed ID: 1416834
[TBL] [Abstract][Full Text] [Related]
12. [Relation between isolation of bacteriophages from Clostridium difficile and cytotoxicity of the strains].
Bernabeu A; Iniesta A; Martín Luengo F
Enferm Infecc Microbiol Clin; 1991 May; 9(5):289-91. PubMed ID: 1954265
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the caecal epithelial barrier during Clostridium difficile infection in the mouse.
Heyman M; Corthier G; Lucas F; Meslin JC; Desjeux JF
Gut; 1989 Aug; 30(8):1087-93. PubMed ID: 2504650
[TBL] [Abstract][Full Text] [Related]
14. Ability of two Clostridium difficile strains from man and hare to produce cytotoxin in vitro and in gnotobiotic rodent intestines.
Corthier G; Dubos F; Raibaud P
Ann Inst Pasteur Microbiol (1985); 1986; 137B(1):113-21. PubMed ID: 3435052
[TBL] [Abstract][Full Text] [Related]
15. Effect of clindamycin on cytotoxin production by Clostridium difficile.
Nakamura S; Mikawa M; Tanabe N; Yamakawa K; Nishida S
Microbiol Immunol; 1982; 26(11):985-92. PubMed ID: 7167065
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice.
Corthier G; Muller MC; Elmer GW; Lucas F; Dubos-Ramaré F
Infect Immun; 1989 Dec; 57(12):3922-7. PubMed ID: 2680988
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
[TBL] [Abstract][Full Text] [Related]
18. Production and release of toxins A and B by Clostridium difficile.
Ketley JM; Haslam SC; Mitchell TJ; Stephen J; Candy DC; Burdon DW
J Med Microbiol; 1984 Dec; 18(3):385-91. PubMed ID: 6389875
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice.
Elmer GW; Corthier G
Can J Microbiol; 1991 Apr; 37(4):315-7. PubMed ID: 1913342
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of cytotoxin production in feces of gnotobiotic mice and rats associated with two strains of Clostridium difficile.
Dubos F; Corthier G; Rapine P; Raibaud P
Prog Clin Biol Res; 1985; 181():207-9. PubMed ID: 4022976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
